Literature DB >> 29471122

Conformational mimetics of the α-methyl chalcone TUB091 binding tubulin: Design, synthesis and antiproliferative activity.

Oskía Bueno1, Gloria Tobajas1, Ernesto Quesada1, Juan Estévez-Gallego2, Sam Noppen3, María-José Camarasa1, José-Fernando Díaz2, Sandra Liekens3, Eva-María Priego4, María-Jesús Pérez-Pérez5.   

Abstract

Based on the conformation of the α-methyl chalcone TUB091 in its complex with tubulin, a series of conformational mimetics have been designed and synthesized where the methyl group of the chalcone has been fused to phenyl ring B resulting in 1,2,3,4-tetrahydronaphthalen-2-yl aryl ketones. Among the synthesized compounds, the 5-amino-6-methoxy derivative, with a similar substitution pattern to that of TUB091, showed antiproliferative activity around 20 nM against tumor and endothelial cells. Tubulin binding experiments confirmed its binding to tubulin at the colchicine site with a Kb of 2.4 × 106 M-1 resulting in the inhibition of the in vitro assembly of purified tubulin. Moreover, based on the recently reported complex of combretastatin A4 (CA4) with tubulin, a comparative analysis of the binding mode of CA4 and the α-methyl chalcone to tubulin has been performed.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antiproliferative activity; Chalcones; Molecular modeling; Tubulin

Mesh:

Substances:

Year:  2018        PMID: 29471122     DOI: 10.1016/j.ejmech.2018.02.019

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia.

Authors:  Deborah Quaglio; Nadezda Zhdanovskaya; Gloria Tobajas; Viviana Cuartas; Silvia Balducci; Michael S Christodoulou; Giancarlo Fabrizi; Marta Gargantilla; Eva-María Priego; Álvaro Carmona Pestaña; Daniele Passarella; Isabella Screpanti; Bruno Botta; Rocco Palermo; Mattia Mori; Francesca Ghirga; María-Jesús Pérez-Pérez
Journal:  ACS Med Chem Lett       Date:  2019-02-26       Impact factor: 4.345

2.  Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo.

Authors:  Shan Lu; Obinna N Obianom; Yong Ai
Journal:  Medchemcomm       Date:  2018-08-27       Impact factor: 3.597

Review 3.  Molecular targets and anticancer activity of quinoline-chalcone hybrids: literature review.

Authors:  Mamdouh F A Mohamed; Gamal El-Din A Abuo-Rahma
Journal:  RSC Adv       Date:  2020-08-21       Impact factor: 4.036

4.  Design and Synthesis of New 6-Nitro and 6-Amino-3,3a,4,5-Tetrahydro-2H-Benzo[g]indazole Derivatives: Antiproliferative and Antibacterial Activity.

Authors:  Viviana Cuartas; María Del Pilar Crespo; Eva-María Priego; Leentje Persoons; Dirk Daelemans; María-José Camarasa; Braulio Insuasty; María-Jesús Pérez-Pérez
Journal:  Molecules       Date:  2019-11-21       Impact factor: 4.411

5.  Novel piperidine derivatives as colchicine binding site inhibitors induce apoptosis and inhibit epithelial-mesenchymal transition against prostate cancer PC3 cells.

Authors:  Dong-Jun Fu; Si-Meng Liu; Jia-Jia Yang; Jun Li
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

6.  α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer.

Authors:  Yohei Saito; Atsushi Mizokami; Kouji Izumi; Renato Naito; Masuo Goto; Kyoko Nakagawa-Goto
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.